Last October, the U.S. Food and Drug Administration (FDA) approved Trikafta to treat cystic fibrosis (CF). The drug’s maker, Vertex Pharmaceuticals, was already riding high on clinical trial data ...
Their research led to the development of a drug that nearly doubles the life expectancy for adult cystic fibrosis patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback